218 related articles for article (PubMed ID: 30500430)
1. Noradrenergic and corticosteroid receptors regulate somatic and motivational symptoms of morphine withdrawal.
Solecki WB; Kus N; Gralec K; Klasa A; Pradel K; Przewłocki R
Behav Brain Res; 2019 Mar; 360():146-157. PubMed ID: 30500430
[TBL] [Abstract][Full Text] [Related]
2. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal.
Navarro-Zaragoza J; Hidalgo JM; Laorden ML; Milanés MV
Br J Pharmacol; 2012 Aug; 166(7):2136-47. PubMed ID: 22364199
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
Navarro-Zaragoza J; Laorden ML; Milanés MV
Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
Navarro-Zaragoza J; Laorden ML; Milanés MV
Addict Biol; 2017 Mar; 22(2):342-353. PubMed ID: 26598419
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal.
Harris GC; Aston-Jones G
Neuropsychopharmacology; 1993 Dec; 9(4):303-11. PubMed ID: 7905738
[TBL] [Abstract][Full Text] [Related]
8. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
[TBL] [Abstract][Full Text] [Related]
9. Beta1 adrenergic receptors in the bed nucleus of stria terminalis mediate differential responses to opiate withdrawal.
Cecchi M; Capriles N; Watson SJ; Akil H
Neuropsychopharmacology; 2007 Mar; 32(3):589-99. PubMed ID: 16823388
[TBL] [Abstract][Full Text] [Related]
10. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
11. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
[TBL] [Abstract][Full Text] [Related]
12. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.
Souza AJ; Guimarães FS; Gomes FV
Behav Brain Res; 2023 Jul; 450():114504. PubMed ID: 37209879
[TBL] [Abstract][Full Text] [Related]
14. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats.
Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W
Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507
[TBL] [Abstract][Full Text] [Related]
15. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis.
Navarro-Zaragoza J; Martínez-Laorden E; Teruel-Fernández FJ; Gómez-Murcia V; Cánovas A; Milanés MV; Laorden ML; Almela P
Pharmacol Biochem Behav; 2021 Feb; 201():173106. PubMed ID: 33444599
[TBL] [Abstract][Full Text] [Related]
16. Distinct regulation pattern of Egr-1, BDNF and Arc during morphine-withdrawal conditioned place aversion paradigm: Role of glucocorticoids.
García-Pérez D; Ferenczi S; Kovács KJ; Milanés MV
Behav Brain Res; 2019 Mar; 360():244-254. PubMed ID: 30550948
[TBL] [Abstract][Full Text] [Related]
17. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
18. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
[TBL] [Abstract][Full Text] [Related]
19. Involvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawal.
Martín F; Núñez C; Marín MT; Laorden ML; Kovács KJ; Milanés MV
PLoS One; 2012; 7(2):e31119. PubMed ID: 22355339
[TBL] [Abstract][Full Text] [Related]
20. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
